Live feed
Filing
SC 13G
SC 13G0001193125-23-012878·Frazier Life Sciences Public Fund, L.P.
Schedule 13G ownership disclosure
THESEUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 88369M101
Event date: 2023-01-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-012878
- Form type
- SC 13G
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Jan 23, 2023
- Reporting period
- Jan 13, 2023
- Description
- Schedule 13G beneficial ownership